celecoxib and trolamine salicylate

celecoxib has been researched along with trolamine salicylate in 104 studies

Research

Studies (104)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (10.58)	18.2507
2000's	73 (70.19)	29.6817
2010's	19 (18.27)	24.3611
2020's	1 (0.96)	2.80

Authors

Authors	Studies
Ziegler, J	1
Miller, JL	1
Nightingale, SL	1
Fort, J; Lipsky, PE; Marshall, KW; Trippel, SB	1
Brink, S	1
Lefkowith, JB	1
Karch, AM; Karch, FE	1
Fung, HB; Kirschenbaum, HL	1
Smigel, K	1
McMorran, M; Morawiecka, I	1
King, DS; Noble, SL; Olutade, JI	1
Urban, MK	1
Davis, JV; Linder, JD; Mönkemüller, KE; Wilcox, CM	1
Kremer, J	1
Everts, B; Hedner, T; Währborg, P	1
Lund, BC; Neiman, RF	1
Burke, T; Goldstein, JL; Maniadakis, N; McGuire, A; Pettitt, D; Schwartz, JS	1
Burke, TA; Goldstein, JL; Maniadakis, N; Maurath, CJ; Pettitt, D; Zabinski, RA	1
Chancellor, JV; de Cruz, E; Hunsche, E; Sarasin, FP	1
Burr, AM; Correa, P; Geis, GS; Goldstein, JL; Hubbard, RC; Verburg, KM; Zhao, WW	1
Davies, NM; de Leeuw, MA; Gudde, TW	1
FitzGerald, GA; Patrono, C	1
Comarow, A	1
Peretz, A	1
Deray, G	1
Simon, LS	1
McColl, GJ	1
FitzGerald, GA	1
Fux, R; Gleiter, CH; Mörike, K	1
Hawkey, CJ	1
Crofford, LJ	1
Dieppe, PA; Jüni, P; Rutjes, AW	1
Fonseré, N; Martí, S; Rego, MJ; Rey-Joly, C	1
Alper, AB; Krane, NK; Meleg-Smith, S	1
Håkansson, J	1
Chan, FK; Chung, SC; Hui, AJ; Hung, LC; Lee, KC; Leung, VK; Leung, WK; Suen, BY; Sung, JJ; To, KF; Wong, VW; Wu, JC	1
Graham, DY	1
Gibofsky, A	1
Bandyopadhyay, D	1
Borer, JS; Faich, G; Makuch, RW; White, WB	1
Horn, FE; Kerr, SJ; Mant, A; McGeechan, K; Sayer, GP	1
Harley, C; Wagner, S	1
Wright, JM	1
Chan, A; Lazarus, DS; Olin, JL	1
Braathen, LR; Goeschke, B	1
Chan, FK; Chung, SC; Hui, AJ; Hung, LC; Lee, YT; Leung, WK; Suen, BY; Sung, JJ; To, KF; Wong, VW; Wu, JC	1
Cryer, B	1
Vanchieri, C	1
Topol, EJ	1
Leo, J	1
Okie, S	1
Chiou, CF; Ofman, JJ; Spiegel, BM	1
Botteman, M; DeLattre, M; Gao, X; Morreale, A; Schaefer, M; Stephens, J	1
Clifford, TM; Johnston, TD; Pajoumand, M	1
Olsen, NJ	1
Krüger, K	1
Cakir, N; Pamuk, ON	1
Allen, MJ; Fleming, I; McLean-Veysey, P	1
Bloom, BJ; Brynskov, J; Kent, JD; Lorenz, RG; Robbins, JL; Sandborn, WJ; Steidle, GM; Stenson, WF	1
Castellsague, J; Maguire, A; Perez-Gutthann, S; Varas-Lorenzo, C	1
Anning, PB; Coles, B; Dey, SK; Marnett, LJ; Morrow, JD; Morton, J; O'Donnell, VB; Uddin, J; Wang, H	1
Mukherjee, D	1
Broich, K; Heim, HK	1
Tabrizchi, R	1
Frampton, JE; Keating, GM	1
Anand, P; Essex, D; Feldmann, M; Inglis, JJ; Notley, CA; Williams, R; Wilson, AW	1
Berger, M; Chan, FK; Niculescu, L; Peura, D; Wilcox, CM	1
Cho, M; Heo, J; Kang, DH; Kim, DS; Kim, GH; Kim, HW; Kim, TO; Lee, CH; Lee, JH; Park, HK; Song, GA	1
Aglianò, AM; Gazzaniga, P; Gianni, W; Gradilone, A; Spadaro, A	1
Lysz, T; O'Connor, JP	1
Diza, E; Gika, HG; Michopoulos, F; Nikolaidis, P; Settas, L; Smith, C; Theodoridis, G; Theodoridou, A; Wilson, ID	1
Becker, MC; Borer, JS; Graham, DY; Husni, ME; Krum, H; Libby, P; Lincoff, AM; Lüscher, TF; Mascette, AM; Nissen, SE; Ruschitzka, F; Solomon, DH; Wang, TH; Wisniewski, L; Wolski, K; Yeomans, ND	1
Baek, YH; Huh, JE; Park, DS	1
Das Roy, L; Gruber, HE; Mukherjee, P; Pathangey, LB; Schettini, JL; Tinder, TL	1
Ross, E	1
Asada, H; Fukumoto, T; Kobayashi, N; Morito, H; Ogawa, K	1
Blackler, R; Bolla, M; Ongini, E; Syer, S; Wallace, JL	1
Essex, MN; Kellner, HL; Li, C	1
Beach, KJ; Brookhart, MA; Layton, JB; Le, HV; Poole, C; Schoenbach, VJ; Stürmer, T	1
Abdollah, H; Averns, HL; Baranchuk, A; Michael, KA; Pizzuto, K; Redfearn, DP; Simpson, C	1
Kaneguchi, A; Kito, N; Moriyama, H; Ozawa, J; Tanaka, R	1
Bao, W; Beckerman, B; Berger, MF; Borer, JS; Gaffney, M; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Ruschitzka, F; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND	1
González-Gay, MA; González-Juanatey, C	1
Grosser, T	1
Nissen, SE	1
Au, KWL; Chan, FKL; Chan, H; Cheong, PK; Ching, JYL; Kee, KM; Kyaw, MH; Lam, K; Lee, V; Lo, A; Ng, SC; Suen, BY; Tse, YK; Wong, GLH; Wong, VWS; Wu, JCY	1
Onuora, S	1
Antman, EM	1
Cañizares, FJ; Cobos, EJ; Entrena, JM; Fernández-Segura, E; Montilla-García, Á; Perazzoli, G; Portillo-Salido, E; Tejada, MÁ	1
Chan, N; Weitz, J	1
Weintraub, WS	1
Laine, L	1
Graham, DY; Yeomans, ND	1
Kadono, T; Kishi, A; Komaki, R; Mitsuishi, S; Miyagaki, T; Miyano, K; Nakajima, K; Okano, T; Suzuki, S; Takeuchi, S	1

Reviews

28 review(s) available for celecoxib and trolamine salicylate

Article	Year
Cyclooxygenase-2 specificity and its clinical implications. The American journal of medicine, 1999, May-31, Volume: 106, Issue:5B Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Membrane Proteins; Osteoarthritis; Pain Measurement; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Treatment Outcome	1999
Selective cyclooxygenase-2 inhibitors for the treatment of arthritis. Clinical therapeutics, 1999, Volume: 21, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Interactions; Humans; Lactones; Pyrazoles; Sulfonamides; Sulfones	1999
Cyclooxygenase-2 enzyme inhibitors: place in therapy. American family physician, 2000, Jun-15, Volume: 61, Issue:12 Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bleeding Time; Blood Platelets; Celecoxib; Cyclooxygenase Inhibitors; Drug Interactions; Duodenal Ulcer; Humans; Lactones; Pyrazoles; Risk Factors; Sulfonamides; Sulfones; United States	2000
COX-2 specific inhibitors offer improved advantages over traditional NSAIDs. Orthopedics, 2000, Volume: 23, Issue:7 Suppl Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Humans; Isoenzymes; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Quality of Life; Sulfonamides; Sulfones	2000
From prostaglandin replacement to specific COX-2 inhibition: a critical appraisal. The Journal of rheumatology. Supplement, 2000, Volume: 60 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Digestive System; Dose-Response Relationship, Drug; Humans; Isoenzymes; Membrane Proteins; Misoprostol; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Stomach Ulcer; Sulfonamides	2000
COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs. Clinical rheumatology, 2000, Volume: 19, Issue:5 Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Lactones; Membrane Proteins; Molecular Structure; Peroxidases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Sulfonamides; Sulfones	2000
Are rofecoxib and celecoxib safer NSAIDS? Drug and therapeutics bulletin, 2000, Volume: 38, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Pyrazoles; Sulfonamides; Sulfones	2000
Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib. Rheumatology (Oxford, England), 2000, Volume: 39 Suppl 2 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cost of Illness; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Middle Aged; Models, Economic; Pyrazoles; Sulfonamides; Treatment Outcome	2000
A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis. PharmacoEconomics, 2001, Volume: 19 Suppl 1 Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Decision Trees; Drug Therapy, Combination; Duodenal Ulcer; Economics, Pharmaceutical; Humans; Misoprostol; Probability; Pyrazoles; Sulfonamides	2001
Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:1 Topics: Absorption; Adenomatous Polyposis Coli; Animals; Arthritis; Celecoxib; Costs and Cost Analysis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	2001
The coxibs, selective inhibitors of cyclooxygenase-2. The New England journal of medicine, 2001, Aug-09, Volume: 345, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Female; Gastrointestinal Diseases; Humans; Isoenzymes; Kidney; Lactones; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Treatment Outcome	2001
[COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?]. Revue medicale de Bruxelles, 2001, Volume: 22, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Belgium; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Humans; Isoenzymes; Lactones; Membrane Proteins; Patient Selection; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Safety; Sulfonamides; Sulfones; Treatment Outcome	2001
Arthritis. Should you be taking a COX-2 inhibitor? Harvard health letter, 2001, Volume: 27, Issue:1 Topics: Advertising; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Lactones; Membrane Proteins; Myocardial Infarction; Patient Education as Topic; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones	2001
COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile? Gastroenterology clinics of North America, 2001, Volume: 30, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Forecasting; Humans; Ibuprofen; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	2001
Pharmacological therapies for the treatment of osteoarthritis. The Medical journal of Australia, 2001, 11-19, Volume: 175, Issue:S3 Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Pyrazoles; Sulfonamides; Sulfones	2001
[Celecoxib]. Deutsche medizinische Wochenschrift (1946), 2002, Apr-12, Volume: 127, Issue:15 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Contraindications; Cyclooxygenase Inhibitors; Digestive System; Humans; Kidney; Pyrazoles; Sulfonamides	2002
Cyclooxygenase inhibition: between the devil and the deep blue sea. Gut, 2002, Volume: 50 Suppl 3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gastroscopy; Humans; Isoenzymes; Kidney; Lactones; Meloxicam; Membrane Proteins; Myocardial Infarction; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfonamides; Sulfones; Thiazines; Thiazoles	2002
Specific cyclooxygenase-2 inhibitors: what have we learned since they came into widespread clinical use? Current opinion in rheumatology, 2002, Volume: 14, Issue:3 Topics: Arthritis; Aspirin; Cardiovascular System; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Isoenzymes; Kidney; Lactones; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk Factors; Sulfonamides; Sulfones	2002
Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2002, Volume: 20, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Pyrazoles; Rheumatic Diseases; Sulfonamides; Sulfones	2002
Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology (Basel, Switzerland), 2004, Volume: 209, Issue:1 Topics: Arm; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Diagnosis, Differential; Drug Eruptions; Exanthema; Face; Female; Humans; Middle Aged; Pyrazoles; Sulfonamides	2004
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis and rheumatism, 2005, Apr-15, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Lactones; Lansoprazole; Naproxen; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Rheumatology; Sulfonamides; Sulfones	2005
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs]. MMW Fortschritte der Medizin, 2005, Aug-04, Volume: 147, Issue:31-32 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Etoricoxib; Gout; Humans; Osteoarthritis; Placebos; Pyrazoles; Pyridines; Rheumatic Diseases; Spondylitis, Ankylosing; Sulfonamides; Sulfones	2005
Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor. Thrombosis and haemostasis, 2006, Volume: 96, Issue:4 Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Humans; Lactones; Pyrazoles; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Sulfones; Thrombosis	2006
Celecoxib: a review of its use in the management of arthritis and acute pain. Drugs, 2007, Volume: 67, Issue:16 Topics: Acute Disease; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Pain; Pyrazoles; Sulfonamides	2007
Celecoxib, NSAIDs and the skeleton. Drugs of today (Barcelona, Spain : 1998), 2008, Volume: 44, Issue:9 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone and Bones; Bone Regeneration; Celecoxib; Humans; Ossification, Heterotopic; Osteoporosis; Pain; Pyrazoles; Spinal Fusion; Sulfonamides; Tendon Injuries	2008
Update on the management of pain in arthritis and the use of cyclooxygenase-2 inhibitors. Current pain and headache reports, 2009, Volume: 13, Issue:6 Topics: Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Pain; Pyrazoles; Sulfonamides	2009
Celecoxib safety revisited. The Medical letter on drugs and therapeutics, 2016, Dec-19, Volume: 58, Issue:1510 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Hemorrhage; Humans; Thrombosis	2016
Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs. Circulation, 2017, May-23, Volume: 135, Issue:21 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiotoxicity; Cardiovascular Diseases; Celecoxib; Clinical Trials, Phase IV as Topic; Humans; Intention to Treat Analysis; Patient Safety; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Risk Assessment; Risk Factors	2017

Trials

9 trial(s) available for celecoxib and trolamine salicylate

Article	Year
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. The American journal of gastroenterology, 2001, Volume: 96, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Humans; Incidence; Male; Middle Aged; Naproxen; Peptic Ulcer; Pyrazoles; Risk Factors; Sulfonamides	2001
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. The New England journal of medicine, 2002, Dec-26, Volume: 347, Issue:26 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer Hemorrhage; Probability; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk Factors; Secondary Prevention; Stomach Ulcer; Sulfonamides	2002
Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology, 2004, Volume: 127, Issue:4 Topics: Adult; Aged; Arthritis; Celecoxib; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Pyrazoles; Recurrence; Sulfonamides	2004
The renal effects of the addition of low-dose aspirin to COX-2 selective and nonselective antiinflammatory drugs. Clinical rheumatology, 2006, Volume: 25, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Blood Pressure; Celecoxib; Clinical Chemistry Tests; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indomethacin; Kidney; Kidney Function Tests; Middle Aged; Pyrazoles; Sulfonamides	2006
Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Colitis, Ulcerative; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Middle Aged; Pilot Projects; Pyrazoles; Recurrence; Sulfonamides	2006
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. American heart journal, 2009, Volume: 157, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Ibuprofen; Middle Aged; Naproxen; Prospective Studies; Pyrazoles; Sulfonamides; Treatment Outcome	2009
Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial. Current medical research and opinion, 2012, Volume: 28, Issue:9 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Humans; Omeprazole; Prospective Studies; Pyrazoles; Sulfonamides	2012
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. The New England journal of medicine, 2016, 12-29, Volume: 375, Issue:26 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Intention to Treat Analysis; Kidney Diseases; Male; Middle Aged; Naproxen; Risk	2016
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet (London, England), 2017, Jun-17, Volume: 389, Issue:10087 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Middle Aged; Naproxen; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Recurrence; Secondary Prevention	2017

Other Studies

67 other study(ies) available for celecoxib and trolamine salicylate

Article	Year
Safer arthritis drugs on the horizon. Harvard health letter, 1998, Volume: 23, Issue:6 Topics: Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	1998
Cancer and arthritis share underlying processes. Journal of the National Cancer Institute, 1998, Jun-03, Volume: 90, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Arthritis; Celecoxib; Cell Transformation, Neoplastic; Colonic Polyps; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Drug Evaluation; Humans; Inflammation; Isoenzymes; Membrane Proteins; Metalloendopeptidases; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Substrate Specificity; Sulfonamides; Tissue Inhibitor of Metalloproteinases	1998
Decisions loom on selective COX-2 inhibitors. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999, Jan-15, Volume: 56, Issue:2 Topics: Arthralgia; Arthritis; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Lactones; Pyrazoles; Sulfonamides; Sulfones; United States; United States Food and Drug Administration	1999
From the Food and Drug Administration. JAMA, 1999, Mar-03, Volume: 281, Issue:9 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Arthritis; Celecoxib; Communicable Diseases; Cyclooxygenase Inhibitors; Drug Contamination; Drug Labeling; Humans; Phenytoin; Plasminogen Activators; Prodrugs; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration; Urokinase-Type Plasminogen Activator	1999
The management of pain and inflammation in orthopedic medicine: question-and-answer period. American journal of orthopedics (Belle Mead, N.J.), 1999, Volume: 28, Issue:3 Suppl Topics: Arthritis; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	1999
Outfoxing pathways of pain. 'COX-2' drugs are easier on stomach. U.S. news & world report, 1998, Dec-14, Volume: 125, Issue:23 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Drug Approval; Humans; Pain; Pyrazoles; Stomach Diseases; Sulfonamides; United States	1998
What did you say? I can't quite understand your spoken order. The American journal of nursing, 1999, Volume: 99, Issue:8 Topics: Antidepressive Agents, Second-Generation; Arthritis; Celecoxib; Citalopram; Cyclooxygenase Inhibitors; Drug Prescriptions; Female; Humans; Medication Errors; Middle Aged; Nursing Staff, Hospital; Pain; Pyrazoles; Speech Intelligibility; Sulfonamides; Terminology as Topic; United States	1999
New versus old drugs for arthritis. Health news (Waltham, Mass.), 1999, Nov-20, Volume: 5, Issue:14 Topics: Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Lactones; Membrane Proteins; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones	1999
Arthritis drug approved for polyp prevention blazes trail for other prevention trials. Journal of the National Cancer Institute, 2000, Feb-16, Volume: 92, Issue:4 Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Approval; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration	2000
Celecoxib (Celebrex): 1 year later. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Apr-04, Volume: 162, Issue:7 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Fatal Outcome; Female; Humans; Male; Middle Aged; Pyrazoles; Risk Factors; Sulfonamides	2000
COX-2 inhibitors and Celebrex: safe or suspect? Health news (Waltham, Mass.), 1999, Jun-01, Volume: 5, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Stomach Ulcer; Sulfonamides	1999
Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia. Southern medical journal, 2000, Volume: 93, Issue:9 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthritis; Atrial Fibrillation; Bicarbonates; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Gastric Mucosa; Gastrointestinal Hemorrhage; Hip Joint; Humans; Hypoprothrombinemias; Incidence; Intestinal Mucosa; Isoenzymes; Lactones; Male; Membrane Proteins; Mucus; Peroxidases; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Warfarin	2000
Visual disturbance associated with celecoxib. Pharmacotherapy, 2001, Volume: 21, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Vision Disorders	2001
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland. PharmacoEconomics, 2001, Volume: 19 Suppl 1 Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Clinical Trials as Topic; Cost of Illness; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Decision Trees; Drug Therapy, Combination; Duodenal Ulcer; Economics, Pharmaceutical; Humans; Probability; Pyrazoles; Sulfonamides; Switzerland	2001
Pain relief at a price. A blow to the heart? U.S. news & world report, 2001, Sep-03, Volume: 131, Issue:8 Topics: Arthritis; Cardiovascular Diseases; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Lactones; Pain; Pyrazoles; Risk; Sulfonamides; Sulfones	2001
[Renal tolerance of selective inhibitors of cyclooxygenase type 2]. Presse medicale (Paris, France : 1983), 2001, Oct-20, Volume: 30, Issue:30 Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diclofenac; Humans; Kidney; Kidney Diseases; Lactones; Naproxen; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Rats; Risk Factors; Sulfonamides; Sulfones; Water-Electrolyte Imbalance	2001
[Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"]. MMW Fortschritte der Medizin, 2001, Nov-15, Volume: 143, Issue:46 Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Lactones; Morphine; Pain, Postoperative; Pyrazoles; Risk Factors; Spinal Fusion; Sulfonamides; Sulfones; Time Factors	2001
[Side effects cause enormous costs. Expensive arthritis therapy]. MMW Fortschritte der Medizin, 2001, Nov-15, Volume: 143, Issue:46 Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Butanones; Celecoxib; Cyclooxygenase Inhibitors; Drug Costs; Gastrointestinal Diseases; Humans; Ibuprofen; Lactones; Nabumetone; Patient Satisfaction; Pyrazoles; Sulfonamides; Sulfones	2001
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach. The American journal of cardiology, 2002, Mar-21, Volume: 89, Issue:6A Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Isoxazoles; Lactones; Male; Pyrazoles; Sulfonamides; Sulfones	2002
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? BMJ (Clinical research ed.), 2002, Jun-01, Volume: 324, Issue:7349 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Ibuprofen; Isoenzymes; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Research Design; Stomach Ulcer; Sulfonamides	2002
[Hyperkalemia and celecoxib]. Medicina clinica, 2002, Jun-08, Volume: 119, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Hyperkalemia; Pyrazoles; Sulfonamides	2002
Nephrotic syndrome and interstitial nephritis associated with celecoxib. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:5 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Glomerular Mesangium; Humans; Isoenzymes; Knee Joint; Male; Membrane Proteins; Microscopy, Electron; Middle Aged; Nephritis, Interstitial; Nephrotic Syndrome; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	2002
[Financial interests characterize published reports on coxiber. Whom can we rely on?]. Lakartidningen, 2002, Oct-03, Volume: 99, Issue:40 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Conflict of Interest; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Industry; Humans; Lactones; Periodicals as Topic; Publication Bias; Publishing; Pyrazoles; Randomized Controlled Trials as Topic; Research Support as Topic; Sulfonamides; Sulfones	2002
NSAIDs, Helicobacter pylori, and Pandora's Box. The New England journal of medicine, 2002, Dec-26, Volume: 347, Issue:26 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	2002
[Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered]. MMW Fortschritte der Medizin, 2003, Mar-06, Volume: 145, Issue:10 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Gastrointestinal Hemorrhage; Humans; Lactones; Pyrazoles; Risk Factors; Sulfonamides; Sulfones; Time Factors	2003
Celecoxib-induced fixed drug eruption. Clinical and experimental dermatology, 2003, Volume: 28, Issue:4 Topics: Administration, Topical; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Clobetasol; Drug Eruptions; Female; Glucocorticoids; Histamine H1 Antagonists; Humans; Middle Aged; Pyrazoles; Sulfonamides	2003
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. The American journal of cardiology, 2003, Aug-15, Volume: 92, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Thrombosis	2003
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners. The Medical journal of Australia, 2003, Oct-20, Volume: 179, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Australia; Celecoxib; Child; Cohort Studies; Cyclooxygenase Inhibitors; Drug Prescriptions; Drug Therapy, Combination; Family Practice; Female; Humans; Lactones; Male; Middle Aged; Pyrazoles; Sulfonamides; Sulfones	2003
Persistence with COX-2 inhibitors in managed care: an analysis of claims data. Managed care interface, 2003, Volume: 16, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Utilization Review; Female; Health Care Costs; Humans; Ibuprofen; Insurance Claim Review; Isoenzymes; Lactones; Male; Managed Care Programs; Membrane Proteins; Middle Aged; Naproxen; Patient Compliance; Proportional Hazards Models; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Regression Analysis; Sulfonamides; Sulfones; United States	2003
Why don't we initiate more large simple randomized controlled trials? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Nov-25, Volume: 169, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Canada; Celecoxib; Consumer Product Safety; Cyclooxygenase Inhibitors; Humans; Lactones; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones	2003
[Homeopathy suppresses COX- and LOX activity. Soft therapy for arthrosis ills]. MMW Fortschritte der Medizin, 2004, Jan-29, Volume: 146, Issue:5 Topics: Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Formularies, Homeopathic as Topic; Homeopathy; Humans; Lactones; Lipoxygenase Inhibitors; Multicenter Studies as Topic; Osteoarthritis, Knee; Placebos; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Time Factors	2004
Pulmonary edema and possible pneumonitis associated with celecoxib. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:6 Topics: Arthritis; Celecoxib; Cyclooxygenase 2; Female; Humans; Isoenzymes; Membrane Proteins; Middle Aged; Pneumonia; Prostaglandin-Endoperoxide Synthases; Pulmonary Edema; Pyrazoles; Sulfonamides	2004
COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers? Gastroenterology, 2004, Volume: 127, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Sulfonamides	2004
Vioxx withdrawal alarms cancer prevention researchers. Journal of the National Cancer Institute, 2004, Dec-01, Volume: 96, Issue:23 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Disease Models, Animal; Estrogen Receptor Modulators; Humans; Lactones; Neoplasms; Pyrazoles; Sulfonamides; Sulfones; Tamoxifen; United States; United States Food and Drug Administration	2004
Arthritis medicines and cardiovascular events--"house of coxibs". JAMA, 2005, Jan-19, Volume: 293, Issue:3 Topics: Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Drug Approval; Humans; Isoxazoles; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration	2005
Multiple comparisons in drug efficacy studies: scientific or marketing principles? Ethical human psychology and psychiatry, 2004,Spring, Volume: 6, Issue:1 Topics: Adult; Arthritis; Attention Deficit Disorder with Hyperactivity; Celecoxib; Child; Clinical Trials as Topic; Combined Modality Therapy; Conflict of Interest; Disclosure; Drug Industry; Humans; Marketing of Health Services; Methylphenidate; National Institute of Mental Health (U.S.); Peer Review, Research; Pharmaceutical Preparations; Publication Bias; Pyrazoles; Research Design; Research Personnel; Sulfonamides; Treatment Outcome; United States	2004
Raising the safety bar--the FDA's coxib meeting. The New England journal of medicine, 2005, Mar-31, Volume: 352, Issue:13 Topics: Advertising; Advisory Committees; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Approval; Drug Industry; Drug Labeling; Humans; Isoxazoles; Lactones; Product Surveillance, Postmarketing; Pyrazoles; Sulfonamides; Sulfones; United States; United States Food and Drug Administration	2005
Assessing the cost-effectiveness of COX-2 specific inhibitors for arthritis in the Veterans Health Administration. Current medical research and opinion, 2005, Volume: 21, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Lactones; Pyrazoles; Quality-Adjusted Life Years; Risk Factors; Sulfonamides; Sulfones; United States; United States Department of Veterans Affairs	2005
Celecoxib-induced nephrotoxicity in a renal transplant recipient. Pharmacotherapy, 2005, Volume: 25, Issue:5 Topics: Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Pyrazoles; Sulfonamides	2005
Tailoring arthritis therapy in the wake of the NSAID crisis. The New England journal of medicine, 2005, Jun-23, Volume: 352, Issue:25 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Pyrazoles; Risk Assessment; Sulfonamides; Sulfones	2005
Coxibs and cardiovascular risk. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Oct-11, Volume: 173, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cardiovascular Diseases; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Pyrazoles; Sulfonamides; Treatment Outcome	2005
Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Computer Simulation; Coronary Disease; Cyclooxygenase Inhibitors; Diclofenac; Female; Heart Failure; Humans; Ibuprofen; Male; Middle Aged; Models, Statistical; Naproxen; Peptic Ulcer; Population Surveillance; Pyrazoles; Risk Assessment; Risk Factors; Stroke; Sulfonamides; United States	2007
Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors. Blood, 2006, Dec-15, Volume: 108, Issue:13 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Arthritis; Biological Availability; Blood Platelets; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Indomethacin; Male; Mice; Mice, Knockout; Nitric Oxide; Pyrazoles; Sulfonamides; Vasoconstriction	2006
Selective COX-2 inhibitors and risk of thromboembolic events - regulatory aspects. Thrombosis and haemostasis, 2006, Volume: 96, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Animals; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Approval; Drug Evaluation, Preclinical; Etoricoxib; European Union; Humans; Lactones; Product Surveillance, Postmarketing; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Sulfones; Thromboembolism	2006
Coxibs: can this class of drugs survive? Vascular health and risk management, 2005, Volume: 1, Issue:1 Topics: Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Etoricoxib; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Lactones; Patient Selection; Pyrazoles; Pyridines; Sulfonamides; Sulfones	2005
Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis and rheumatism, 2007, Volume: 56, Issue:12 Topics: Animals; Arthritis; Astrocytes; Behavior, Animal; Celecoxib; Collagen; Cyclooxygenase Inhibitors; Disease Models, Animal; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Mice; Mice, Inbred DBA; Microglia; Pain; Pyrazoles; Sulfonamides; Tumor Necrosis Factor-alpha	2007
Response to Ray and colleagues: the called-for large clinical trial is already ongoing. Gastroenterology, 2008, Volume: 134, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Celecoxib; Diclofenac; Humans; Omeprazole; Peptic Ulcer; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides	2008
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. Journal of Korean medical science, 2008, Volume: 23, Issue:3 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arthritis; Celecoxib; Drug Eruptions; Eosinophilia; Ethambutol; Female; Humans; Myositis; Pyrazoles; Sulfonamides; Syndrome; Tuberculosis, Pulmonary	2008
Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders. Clinical and experimental medicine, 2008, Volume: 8, Issue:4 Topics: Arthritis; ATP Binding Cassette Transporter, Subfamily B; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lymphocytes; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides	2008
Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography-inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry. Journal of pharmaceutical and biomedical analysis, 2009, Apr-05, Volume: 49, Issue:3 Topics: Adult; Aged; Arthritis; Celecoxib; Chromatography, High Pressure Liquid; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Humans; Male; Mass Spectrometry; Middle Aged; Pyrazoles; Pyridines; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Sulfones; Synovial Fluid; Young Adult	2009
Therapeutic effect of Aralia cordata extracts on cartilage protection in collagenase-induced inflammatory arthritis rabbit model. Journal of ethnopharmacology, 2009, Sep-07, Volume: 125, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Aralia; Arthritis; Cartilage; Caspase 3; Celecoxib; Chondrocytes; Collagenases; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Down-Regulation; Inflammation Mediators; Phytotherapy; Plant Extracts; Pyrazoles; Rabbits; Sulfonamides	2009
Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast cancer research : BCR, 2009, Volume: 11, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arthritis; Autoimmune Diseases; Bone Neoplasms; Bronchoalveolar Lavage Fluid; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Models, Animal; Female; Interleukin-17; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Neoplasm Metastasis; Organ Specificity; Osteoclasts; Pyrazoles; Sulfonamides; ZAP-70 Protein-Tyrosine Kinase	2009
Drug-induced hypersensitivity syndrome followed by persistent arthritis. The Journal of dermatology, 2012, Volume: 39, Issue:2 Topics: Anti-Arrhythmia Agents; Arthralgia; Arthritis; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibitors; DNA, Viral; Drug Hypersensitivity; Drug Therapy, Combination; Exanthema; Female; Herpesvirus 6, Human; Humans; Matrix Metalloproteinase 3; Mexiletine; Middle Aged; Prednisolone; Pyrazoles; Sulfonamides; Treatment Outcome	2012
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence. PloS one, 2012, Volume: 7, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Hypertension; Male; Naproxen; Nitrates; Obesity; Omeprazole; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Wistar; Rats, Zucker; Sulfonamides	2012
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. BMC medical research methodology, 2013, Nov-19, Volume: 13 Topics: Adolescent; Adult; Aged; Algorithms; Arthritis; Celecoxib; Confounding Factors, Epidemiologic; Cyclooxygenase 2 Inhibitors; Diclofenac; Gastrointestinal Diseases; Hemorrhage; Humans; Ibuprofen; Incidence; Middle Aged; Models, Statistical; Prevalence; Propensity Score; Pyrazoles; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides; Treatment Outcome; Young Adult	2013
Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2014, Volume: 19, Issue:1 Topics: Analysis of Variance; Arthritis; Atrial Fibrillation; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Electrocardiography; Female; Heart Atria; Humans; Male; Middle Aged; Prospective Studies; Pyrazoles; Sulfonamides	2014
Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees. BMC musculoskeletal disorders, 2016, 10-24, Volume: 17, Issue:1 Topics: Administration, Oral; Animals; Arthritis; Celecoxib; Contracture; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Humans; Immobilization; Knee Joint; Male; Muscle, Skeletal; Nociception; Range of Motion, Articular; Rats; Rats, Wistar; Treatment Outcome	2016
Inflammation: NSAIDs and cardiovascular risk in arthritis. Nature reviews. Cardiology, 2017, Volume: 14, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Humans; Ibuprofen; Inflammation; Naproxen; Risk Factors	2017
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. The New England journal of medicine, 2017, 04-06, Volume: 376, Issue:14 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Humans; Ibuprofen; Naproxen; Pyrazoles; Sulfonamides	2017
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. The New England journal of medicine, 2017, 04-06, Volume: 376, Issue:14 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Humans; Ibuprofen; Naproxen; Pyrazoles; Sulfonamides	2017
Therapy: Celecoxib reduces risk of ulcer bleeding. Nature reviews. Rheumatology, 2017, Volume: 13, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Double-Blind Method; Gastrointestinal Hemorrhage; Humans; Naproxen; Ulcer	2017
Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia. Neuropharmacology, 2017, Volume: 125 Topics: Acetaminophen; Analgesics; Animals; Arthritis; Celecoxib; Disease Models, Animal; Diterpenes; Female; Freund's Adjuvant; Hand Strength; Hyperalgesia; Ibuprofen; Inflammation; Muscle Strength; Nociceptors; Oxycodone; Pain Measurement; Rheumatic Diseases; Ruthenium Red; Tarsus, Animal; Touch; Tramadol; TRPV Cation Channels	2017
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding. Annals of internal medicine, 2017, 08-15, Volume: 167, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Naproxen; Pyrazoles; Sulfonamides	2017
Safety of non-steroidal anti-inflammatory drugs. European heart journal, 2017, 11-21, Volume: 38, Issue:44 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Celecoxib; Humans; Ibuprofen; Naproxen; Prospective Studies	2017
Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Ibuprofen; Naproxen	2018
Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Ibuprofen; Naproxen	2018
Arthritis and enthesitis during dupilumab therapy completely remitted by celecoxib. The Journal of dermatology, 2021, Volume: 48, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Arthritis; Arthritis, Psoriatic; Celecoxib; Enthesopathy; Humans	2021